menu

Medical Program: How KEYNOTE-189 Transformed Clinical Practice Overnight

Be part of the knowledge.
Register

ReachMD is even better when
you join the community!
Registration is free and easy.

Register Now

How KEYNOTE-189 Transformed Clinical Practice Overnight

How KEYNOTE-189 Transformed Clinical Practice Overnight
RestartResume
Delivering long-anticipated data, Keynote-189 has unlocked new, progressive paradigms in NSCLC care.
  • Sponsored by

  • Overview

    Proven to be both statistically and clinically significant, KEYNOTE-189 has offered pivotal outcomes for patients with non-small cell lung cancer (NSCLC). Join Dr. Howard Jack West as he analyzes the substantial influence of this clinical trial. 

    Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

Facebook Comments

You must be in to display playlists.

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.